Michael Exton Insider Profile
4 Followers
Michael Exton, CEO, Director at Lexicon Pharmaceuticals, holds 298.43K shares in Lexicon Pharmaceuticals (Ticker: LXRX).
Michael Exton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Michael Exton holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Exton
Michael Exton's Trading History
List of latest transactions for each holding click on a transaction to see Michael Exton's performance on stock
You May Also Like
Michael Exton insider profile FAQ
What is the percentage of profitable transactions made by Michael Exton?
The percentage of profitable transactions made by Michael Exton is ―.
What is the average return per transaction made by Michael Exton?
The average return per transaction made by Michael Exton is ―.
What stocks does Michael Exton hold?
Michael Exton holds: LXRX stocks.
What was Michael Exton’s latest transaction?
Michael Exton latest transaction was an Uninformative Buy of $438.70K.
What was Michael Exton's most profitable transaction?
Michael Exton’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Exton's role in Lexicon Pharmaceuticals?
Michael Exton's role in Lexicon Pharmaceuticals is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.